retatrutide fda approval 2026 HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III CLINICAL TRIALS⛔️ Retatrutide is not currently FDA-approved, as it is in Phase III clinical trials with anticipated completion in 2025–2026 and Retatrutide for Weight Loss: TRIUMPH-1

Serious legal action is now being taken against the manufacturer over reports of severe health complications linked to prolonged use of the drug for on and off-label reasons

Evaluate your previous experience

Congenital note: K22.2 covers acquired strictures

[DOI] [PMC free article] [PubMed] [Google Scholar] 6.Aberer F., Hochfellner D.A., Sourij H., Mader J.K

At Direct Aesthetics, were committed to helping you achieve real results with personalized semaglutide treatment plans, expert guidance on nutrition and exercise, and ongoing support to ensure your journey is safe, effective, and confidence-boosting

Announced in June 2025, the CNPV program aims to expedite the review of drugs that address unmet medical needs, improve affordability, or support public health priorities